Loading clinical trials...
Loading clinical trials...
A Single-Blind Study of the Safety, Pharmacokinetics and Pharmacodynamics of Escalating Repeat Doses of GSK249320 in Patients With Stroke
Conditions
Interventions
GSK249320
PLACEBO
Locations
15
United States
GSK Investigational Site
Los Angeles, California, United States
GSK Investigational Site
Orange, California, United States
GSK Investigational Site
Fort Collins, Colorado, United States
GSK Investigational Site
Detroit, Michigan, United States
GSK Investigational Site
Portland, Oregon, United States
GSK Investigational Site
Toronto, Ontario, Canada
Start Date
July 8, 2009
Primary Completion Date
January 31, 2011
Completion Date
January 31, 2011
Last Updated
November 17, 2017
Lead Sponsor
GlaxoSmithKline
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions